Associate Director, Tax Counsel at Bristol-Myers Squibb

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

J.D., bachelor’s degree in accounting or finance is a plus, with LL.M preferred
4+ years corporate tax experience at a law firm, big 4 accounting firm, and/or corporate tax department
Foundation in federal corporate income tax analysis, particularly subchapter C, M&A, subpart F (including substantial contribution analysis), foreign tax credit planning, and transfer pricing
Well-rounded expertise in global operations, US and international tax issues, international tax planning, transfer pricing, and cross-border M&A
Strong understanding of tax accounting preferred
Strong organizational, analytical, communication, and interpersonal skills with proven ability to solve multidimensional problems creatively
Ability to prioritize and handle multiple tasks in fast-paced environment
Business-oriented with desire and ability to collaborate cross functionally

Responsibilities

Analyze U.S. and foreign tax issues for various internal and external transactions, including U.S. international tax analysis under GILTI, Subchapter C and K, and other provisions, support and reporting of the Company’s position for the manufacturing exception under subpart F (“substantial contribution”), and Pillar II analysis
Ensure proper integration planning and execution for acquisitions, divestures, legal entity restructurings, cross-border transactions, licensing arrangements, collaborations, partnerships, and other strategic transactions including any business changes occurring globally, partnering with external advisors when needed
Advise and partner with other stakeholders across the company, including finance, business development, legal, HR, commercial, R&D, and manufacturing departments, on tax efficient and compliant operations and understand business needs and objectives
Provide tax-efficient cash management planning advice, working closely with the treasury team
Provide tax advice and financial modeling of taxes for the company’s ongoing and new business development initiatives
Monitor and analyze federal, state, and foreign legal developments and changes for impacts to the company to ensure proper compliance
Develop strategies to address potential challenges for federal, foreign, and state and local tax controversies
Coordinate with tax compliance and provision functions to ensure proper reporting of transactions
Support the foreign markets in managing relationships with external tax advisors and local tax authorities
Support the development and implementation of transfer pricing policies and strategies to comply with transfer pricing regulations and documentation requirements

Skills

Tax Strategy

Tax Planning

US International Tax

GILTI

Subchapter C

Subchapter K

Subpart F

Pillar II

M&A Tax

Cross-Border Transactions

Licensing Agreements

Entity Restructuring

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free